Auto-Enrollment

Auto-Enrollment is a significant feature within employer-sponsored 401(k) retirement plans, designed to boost employee participation and retirement savings. In this context, Auto-Enrollment refers to the practice of automatically enrolling eligible employees into the company's 401(k) plan, without requiring them to actively opt-in.

The process typically begins shortly after an employee becomes eligible for the plan, usually after a specific waiting period, such as three to six months of service. Once eligible, employees are automatically enrolled in the 401(k) plan, with a default contribution rate and investment option. This default contribution rate is often set at a conservative level, such as 3% of the employee's salary, but employees have the flexibility to adjust it to a higher or lower percentage according to their preference.

Example 1: John starts working at Company X and, after completing his three-month probation period, he is automatically enrolled in the company's 401(k) plan with a default contribution rate of 3% of his salary.

Example 2: Sarah joins a new job at Company Y. Due to the auto-enrollment feature, she becomes a participant in the 401(k) plan after six months of employment, with a default contribution rate of 4% of her salary.

Example 3: In an effort to encourage retirement savings among its workforce, Company Z adopts auto-enrollment with a default contribution rate of 5% for all eligible employees, increasing the likelihood of higher retirement readiness across the organization.

Auto-Enrollment is considered a powerful tool in promoting retirement preparedness, as it simplifies the process of joining the plan and encourages employees to start saving for their future without the need for proactive action on their part.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.